Tetanus Vaccine Market Research with top 8 Key Players - GlaxoSmithKline plc, Pfizer,Inc, Merck & Co.,Inc, Sanofi Pasteur SA, Biological E

The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

Global Tetanus Vaccine Market encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the market for Tetanus Vaccine Sales would rise at a positive CAGR during the period 2018-2023.

Download PDF Sample Of this Report @ https://www.reporthive.com/enquiry.php?id=1618514&req_type=smpl

Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.

A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

Market Segment by Manufacturers, this report covers:
• GlaxoSmithKline plc
• Pfizer,Inc
• Merck & Co.,Inc
• Sanofi Pasteur SA
• Biological E
• Dano Vaccine &Biological Pvt.Ltd., and More....

Market Segment by Type, covers:
• Diphtheria and tetanus (DT) vaccines
• Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
• Tetanus and diphtheria (Td) vaccines
• Tetanus, diphtheria, and pertussis (Tdap) vaccines

Market Segment by Applications, can be divided into:
• Adult
• Pediatric

Click Here for Purchase Full Report with Full TOC @ https://www.reporthive.com/enquiry.php?id=1618514&req_type=purch

If you have any special requirements, please let us know and we will offer you the report as you want.

Research objectives
• Focuses on the key global Tetanus Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Tetanus Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Tetanus Vaccine submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. and More…

Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tetanus Vaccine Consumption 2013-2023
2.1.2 Tetanus Vaccine Consumption CAGR by Region
2.2 Tetanus Vaccine Segment by Type
2.2.1 Diphtheria and tetanus (DT) vaccines
2.2.2 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
2.2.3 Tetanus and diphtheria (Td) vaccines
2.2.4 Tetanus, diphtheria, and pertussis (Tdap) vaccines
2.3 Tetanus Vaccine Consumption by Type
2.3.1 Global Tetanus Vaccine Consumption Market Share by Type (2013-2018)

3 Global Tetanus Vaccine by Players
3.1 Global Tetanus Vaccine Sales Market Share by Players
3.1.1 Global Tetanus Vaccine Sales by Players (2016-2018)
3.1.2 Global Tetanus Vaccine Sales Market Share by Players (2016-2018)
3.2 Global Tetanus Vaccine Revenue Market Share by Players
3.2.1 Global Tetanus Vaccine Revenue by Players (2016-2018)
3.2.2 Global Tetanus Vaccine Revenue Market Share by Players (2016-2018)
3.3 Global Tetanus Vaccine Sale Price by Players
TOC Continued….!

Tables And Figures
• Figure Picture of Tetanus Vaccine
• Table Product Specifications of Tetanus Vaccine
• Figure Tetanus Vaccine Report Years Considered
• Figure Market Research Methodology
• Figure Global Tetanus Vaccine Consumption Growth Rate 2013-2023 (K Units)
• Figure Global Tetanus Vaccine Value Growth Rate 2013-2023 ($ Millions)
• Table Tetanus Vaccine Consumption CAGR by Region 2013-2023 ($ Millions)
• Figure Product Picture of Diphtheria and tetanus (DT) vaccines
• Table Major Players of Diphtheria and tetanus (DT) vaccines
• Figure Product Picture of Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines and More….

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
http://www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.